HomeNewsAventis

Aventis

Jump to

Sanofi India Q2 net up 12% at Rs 64.2 crore

Standalone total income from operations also rose to Rs 549.7 crore for the quarter ended June 30, 2015 as against Rs 505.8 crore for the same period year ago, Sanofi India said in a filing to the BSE.
Stocks in news: RIL, Oil India, Tata Power, IOC, Aventis

RIL | Oil India | Tata Power | IOC | Aventis and Crisil are stocks, which are in the news today.
Cadila's JV Hospira gets US nod: How will it impact Sun?

Cadila Healthcare's joint venture partner Hospira won approval from US FDA for generic version of Sanofi-Aventis' cancer drug Taxotere. CNBC-TV18's Ekta Batra reports on how will this impact Sun Pharma and Cadila Health.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Aventis

Sanofi India Q2 net up 12% at Rs 64.2 crore

Stocks in news: RIL, Oil India, Tata Power, IOC, Aventis

Cadila's JV Hospira gets US nod: How will it impact Sun?